The development of an HIV-1 vaccine that would be effective against all existing subtypes and circulating recombinant forms remains one of the great scientific and public health challenges of our generation. One of the major barriers to HIV-1 vaccine development is a lack of understanding of the correlates of protective immunity against the virus. In this context, research has focused on the rare phenomenon of spontaneous control of HIV-1 infection, in groups referred to as 'long-term nonprog...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
An underestimated lentivirus model: what can HIV-2 research contribute to the development of an effective HIV-1 vaccine?
If you are the owner of this record, you can report an update to it here: Report update to this record